Chemed (CHE)
(Delayed Data from NYSE)
$417.85 USD
+5.55 (1.35%)
Updated Aug 1, 2025 03:58 PM ET
After-Market: $417.79 -0.06 (-0.01%) 7:58 PM ET
5-Strong Sell of 5 5
C Value A Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CHE 417.85 +5.55(1.35%)
Will CHE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
Chemed (CHE) Q2 Earnings Miss Estimates
ASTH vs. CHE: Which Stock Is the Better Value Option?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for
ASTH or CHE: Which Is the Better Value Stock Right Now?
Reasons to Add Align Technology Stock to Your Portfolio Now
Other News for CHE
Dividend Champion, Contender, And Challenger Highlights: Week Of August 3
Chemed (CHE) Announces 20% Increase in Quarterly Dividend
Chemed (CHE) Expands Share Buyback Program with Additional $300 Million
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock ...
Chemed board declares increased quarterly dividend of 60c per share